Lopinavir and Ritonavir

Strengths & Sizes

Note: product and packaging images are not actual size

NDC#31722-603-60
UPC Code331722603607
ImprintH/L7
GPI Code1219902550310

Download Label

Download HDA Sheet

Note: product and packaging images are not actual size

NDC#31722-556-12
UPC Code331722556125
ImprintH/70
GPI Code12109902550320

Download Label

Download HDA Sheet

Product Info

Dosage FormTablet

TE CodeAB

Brand ReferenceKaletra

Therapeutic CategoryProtease Inhibitors

Pronunciationloe PIN a veer & ri TOE na vir

Inactive IngredientsLopinavir and Ritonavir Tablets USP, 200 mg/50 mg: colloidal silicon dioxide, copovidone, sodium stearyl fumarate, sorbitan monolaurate and opadry yellow which contains colloidal anhydrous silica, hypromellose, hydroxypropyl cellulose, iron oxide yellow, polyethylene glycol, polysorbate 80, talc and titanium dioxide. Lopinavir and Ritonavir Tablets USP, 100 mg/25 mg: colloidal silicon dioxide, copovidone, sodium stearyl fumarate, sorbitan monolaurate and opadry yellow which contains colloidal anhydrous silica, hypromellose, hydroxypropyl cellulose, iron oxide yellow, polyethylene glycol, polysorbate 80, talc and titanium dioxide.

Lopinavir and Ritonavir

Kaletra

Strengths & Sizes

Leaders in Product Approvals & Launches